By Benjamin Chiou
Date: Tuesday 04 Aug 2026
(Sharecast News) - Convatec reiterated its full-year guidance on Tuesday after delivering first-half results in line with expectations, with the medical products group forecasting stronger revenue and margins in the second half.
| Holding(s) in Company | 02-Oct-2026 | 11:00 | RNS |
| Total Voting Rights | 01-Oct-2026 | 11:05 | RNS |
| Holding(s) in Company | 01-Oct-2026 | 11:00 | RNS |
| Transaction in Own Shares | 28-Sep-2026 | 11:00 | RNS |
| Holding(s) in Company | 24-Sep-2026 | 11:00 | RNS |
| Convatec raises outlook with new specialist medi... | 25-Feb-2026 | Times |
No recent information was found.
No recent information was found.
| Currency | UK Pounds |
| Share Price | 216.60p |
| Change Today | -0.20p |
| % Change | -0.09 % |
| 52 Week High | 256.40 |
| 52 Week Low | 194.00 |
| Volume | 12,416,703 |
| Shares Issued | 1,917.32m |
| Market Cap | £4,152.93m |
| Beta | 0.00 |
| RiskGrade | 96 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 20-Aug-26 | 16-Apr-26 |
| Paid | 30-Sep-26 | 28-May-26 |
| Amount | 2.17¢ | 5.37¢ |
| Time | Volume / Share Price |
| 16:37 | 5,257 @ 216.60p |
| 16:37 | 4,553 @ 216.60p |
| 16:37 | 3,729 @ 216.60p |
| 16:37 | 9,750 @ 216.60p |
| 16:35 | 700,000 @ 216.60p |
| Chair | John McAdam |
| CEO | Jonny Mason |
| CFO | Fiona Ryder |
You are here: research